Clin Med (Lond). 2025 Dec 18:100547. doi: 10.1016/j.clinme.2025.100547. Online ahead of print.
ABSTRACT
BACKGROUND: Metabolic syndrome is a constellation of cardiovascular risk factors and has been associated with a higher risk of mortality. Albuminuria was previously part of the criteria for metabolic syndrome. We investigated the associations of albuminuria and metabolic syndrome with all-cause mortality among patients with coronary artery disease.
METHODS: We enrolled patients who had coronary angiography proved coronary artery disease but no history of diabetes between 2009 and 2013. All patients underwent an oral glucose tolerance test to determine their glucose regulation state. Metabolic syndrome was determined using the criteria of National Cholesterol Education Program Adult Treatment Panel III. A spot urine sample was collected to determine the urinary albumin to creatinine ratio (UACR). Information on all-cause mortality was confirmed until March 2023. Cox-proportional hazard models were conducted to examine the associations of metabolic syndrome and albuminuria with all-cause mortality.
RESULTS: A total of 823 patients with coronary artery disease were analysed. After a median follow-up period of 8.94 years, patients with metabolic syndrome had no significant difference in all-cause mortality compared with those without metabolic syndrome (adjusted hazard ratio [HR] 0.826, 95% CI 0.568 to 1.201, p=0.317). In contrast, patients with albuminuria (UACR ≥ 30 mg/g) had an independently higher risk of all-cause mortality (adjusted HR 1.529, 95% CI 1.057 to 2.212, p=0.024) compared with those who had normoalbuminuria.
CONCLUSIONS: Albuminuria was independently associated with all-cause mortality in patients with coronary artery disease but no history of diabetes, while the presence of metabolic syndrome was not.
PMID:41421665 | DOI:10.1016/j.clinme.2025.100547